Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Secondhand Smoke a Danger to Health – Germany Must Take Action

German Cancer Research Center presents a new study

No. 71 | 07/12/2005 | by (MPL/JR)

Tobacco smoke in enclosed spaces is not simply a nuisance: it is a threat to health with fatal consequences. This is the conclusion reached by the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in its latest publication.

“Secondhand smoke contains not only poisons such as hydrocyanic acid, ammonia, and carbon monoxide, but also numerous carcinogenic substances including polycyclic aromatic hydrocarbons, N-nitrosamines, aromatic amines, benzene, vinyl chloride, arsenic, cadmium, chromium and the radioactive isotope polonium 210,” states Dr. Martina Pötschke-Langer, the editor of the publication. “For the carcinogenic substances contained in secondhand smoke it is impossible to determine threshhold values under which no health risk is to be expected. Even the slightest exposure can contribute to the development of tumors.”

In Germany, the level of pollution due to tobacco smoke is considerable: Each year more than 170,000 newborn babies have already been exposed in the womb to the harmful substances contained in tobacco smoke, and an estimated 8 million or more children and teenagers under 18 years old live in a household with at least one smoker. Among the adult population, more than 35 million nonsmokers are forced to inhale the harmful substances contained in secondhand smoke – at home, at work, or in their leisure time. At the workplace alone, about 8.5 million nonsmokers are still exposed to secondhand smoke.

Secondhand smoke irritates the respiratory tract and can lead to breathlessness during physical activity, increased susceptibility to infection, headaches and dizziness. Even a short exposure can elicit these symptoms. However, secondhand smoke is also a contributory factor in the causation of chronic and fatal diseases.

The joint authors of the study, the epidemiologists Professor Dr. Ulrich Keil of the University of Muenster and Professor Dr. Heiko Becher of Heidelberg University made the first ever calculation of the annual number of fatalities in Germany due to secondhand smoke: “Every year, secondhand smoke causes the deaths of an estimated 2140 nonsmokers due to coronary heart disease, 770 nonsmokers due to stroke, 50 nonsmokers due to chronic obstructive pulmonary disease, and 260 nonsmokers due to lung cancer. Approximately 60 infants die each year as a result of secondhand smoke in the household or from prenatal exposure to harmful substances, because the mother smoked during pregnancy,” explain Ulrich Keil and Heiko Becher.
The two epidemiologists emphasize: “In Germany, more than 3300 nonsmokers probably die each year as a consequence of exposure to secondhand smoke. This is a larger number of fatalities than the annual toll from illegal drugs, asbestos, BSE and SARS combined.”

Secondhand smoke is also a contributory factor in the occurrence of numerous non-fatal cases of coronary heart disease, stroke, and chronic obstructive pulmonary disease.
Dr. Martina Pötschke-Langer considers the present level of exposure of nonsmokers to tobacco smoke in Germany as inacceptable. In view of the estimated 3300 or more annual deaths and the countless persons who are ill because of secondhand smoke, it is urgent that a federal bill be introduced to ensure comprehensive protection of nonsmokers in public premises, including restaurants. An information campaign in Germany, drawing attention to the dangers of secondhand smoke would also contribute to reducing the number of victims. Germany needs to take action!

The publication “Passivrauchen - ein unterschätztes Gesundheitsrisiko“ (“Secondhand smoke – an underestimated health risk”) was authored by scientists from the German Cancer Research Center (DKFZ), Heidelberg, the Institute for Epidemiology and Social Medicine of the University of Muenster, and the Hygiene Institute of the Heidelberg University Hospital. It can be obtained as a pdf file from www.tabakkontrolle.de and in printed form from:

Deutsches Krebsforschungszentrum
WHO Collaborative Center for Tobacco Control
Fax: +49 6221 42 30 20
or by e-mail: who-cc@dkfz.de

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS